Variables | Total (n = 329) | Group 1 (n = 258) | Group 2 (n = 71) | P-value | Group I (n = 89) | Group II (n = 240) | P-value |
---|---|---|---|---|---|---|---|
Age (years) | 65.0 (56.0–71.0) | 65.0 (57.0–71.0) | 64.0 (54.0–69.0) | 0.131 | 69.0 (61.5–75.5) | 64.0 (56.0–69.0) | 0.000 |
Sex (n/%) | 0.297 | Â | 0.356 | ||||
 Male | 186 (56.5) | 142 (55.0) | 44 (62.0) | 54 (60.7) | 132 (55.0) | ||
 Female | 143 (43.5) | 116 (45.0) | 27 (38.0) | 35 (39.3) | 108 (45.0) | ||
Smoking history (n/%) | 63 (19.1) | 52 (20.2) | 11 (15.5) | 0.377 | 15 (16.9) | 48 (20.0) | 0.519 |
Alcohol history (n/%) | 40 (12.2) | 33 (12.8) | 7 (9.9) | 0.503 | 31 (12.9) | 9 (10.1) | 0.489 |
ASA class (n/%) | 0.219 | Â | 0.000 | ||||
 I | 9 (2.7) | 5 (1.9) | 4 (5.6) | 1 (1.1) | 8 (3.3) | ||
 II | 259 (78.7) | 206 (79.8) | 53 (74.6) | 58 (65.2) | 201 (83.8) | ||
 III | 61 (18.5) | 3 (18.2) | 14 (19.7) | 30 (33.7) | 31 (12.9) | ||
Diabetes (n/%) | 75 (22.8) | 55 (21.3) | 20 (28.2) | 0.223 | 24 (27.0) | 51 (21.3) | 0.272 |
HbA1c (%) | 5.8 (5.3–6.7) | 5.7 (5.3–6.5) | 6.2 (5.4–6.8) | 0.106 | 5.8 (5.2–7.8) | 5.8 (5.3–6.6) | 0.618 |
Hypertension (n/%) | 115 (35.0) | 87 (33.7) | 28 (39.4) | 0.371 | 31 (34.8) | 84 (35.0) | 0.977 |
CHD (n/%) | 8 (2.4) | 4 (1.6) | 4 (5.6) | 0.070 | 2 (2.2) | 6 (2.5) | 1.000 |
ALT (U/L) | 107.8 (31.0–243.6) | 108.3 (28.4–253.5) | 107.3 (38.4–233.2) | 0.723 | 110.5 (48.6–172.0) | 105.2 (22.0–275.6) | 0.833 |
CRP (mg/L) | 5.8 (2.8–13.8) | 5.7 (2.8–12.9) | 6.8 (2.9–15.3) | 0.574 | 8.4 (5.5–26.1) | 4.8 (2.4–11.8) | 0.000 |
CEA (ng/ml) | 3.2 (2.2–4.8) | 3.3 (2.2–5.1) | 3.1 (2.1–4.5) | 0.313 | 3.4 (2.5–5.1) | 3.2 (2.1–4.7) | 0.279 |
CA-199 (U/ml) | 115.6 (35.3–367.0) | 122.1 (34.7–423.4) | 100.5 (39.7–321.4) | 0.601 | 168.9 (42.9–718.5) | 108.6 (31.7–218.3) | 0.022 |
BMI (kg/m2) | 22.8 (20.8–24.8) | 22.0 (20.3–23.4) | 26.4 (25.6–27.3) | 0.000 | 22.5 (20.5–24.4) | 22.9 (21.0–24.8) | 0.517 |
Albumin (g/L) | 37.4 (34.5–40.5) | 37.4 (34.4–40.2) | 38.8 (34.5–41.3) | 0.205 | 33.1 (30.7–33.9) | 39.3 (37.0–41.8) | 0.000 |
TB (mmol/L) | 81.5 (15.0–200.7) | 81.7 (14.8–200.1) | 77.7 (16.3–201.9) | 0.454 | 153.8 (58.9–288.5) | 37.4 (12.8–165.1) | 0.000 |
Cancer stage (n/%) | 0.141 | Â | 0.009 | ||||
 I | 118 (35.9) | 96 (37.2) | 22 (31.0) | 43 (48.3) | 75 (31.3) | ||
 II | 161 (48.9) | 128 (49.6) | 33 (46.5) | 32 (36.0) | 129 (53.8) | ||
 III | 50 (15.2) | 34 (13.2) | 16 (22.5) | 14 (15.7) | 36 (15.0) | ||
Location (n/%) | 0.076 | Â | 0.009 | ||||
 Pancreas | 229 (69.6) | 181 (70.2) | 48 (67.6) | 50 (56.2) | 179 (74.6) | ||
 Ampulla of Vater | 27 (8.2) | 22 (8.5) | 5 (7.0) | 12 (13.5) | 15 (6.3) | ||
 Duodenum | 34 (10.3) | 30 (11.6) | 4 (5.6) | 14 (15.7) | 20 (8.3) | ||
 Common bile duct | 39 (11.9) | 25 (9.7) | 14 (19.7) | 13 (14.6) | 26 (10.8) |